Hemostasis Diagnostics Market Research Report Comprehensive Insights, Size, Share, Growth, Investment, Competitive Analysis, Application Opportunities and Forecast 2019-2026
Global Hemostasis Diagnostics Market – Insights
Hemostasis is a process used for healing wounds after a vascular injury and involves slowing and stopping the blood flow. Blood is gets converted to gelatinous state during the process. Three mechanisms — vasoconstriction, platelet plug formation, and blood coagulation maintain hemostasis in the body. Hemostasis diagnostics is used to identify the hemostatic defects that may lead to excessive bleeding. It also aids in determining the cause of excessive bleeding during the surgery and the hemostatic defects in patients with a history of excessive bleeding.
Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/434
Global Hemostasis Diagnostics Market: Drivers
Increasing incidence of hemophilia is expected to boost growth of the global hemostasis diagnostics market over the forecast period. For instance, according to the National Hemophilia Foundation in 2012, the global incidence of hemophilia was estimated to be 400,000 people. Moreover, increasing cases of trauma, high number of surgeries, and rapid adoption of recombinant products is also expected to propel growth of the market.
Increasing technological development in molecular diagnostics, availability of cheap and biodegradable diagnostic products, chromogenic substrates, monoclonal antibodies, immunoassays, and increasing automation of laboratories is also expected to aid in growth of the market.
Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/434
Global Hemostasis Diagnostics Market- Taxonomy
The global hemostasis diagnostics market is segmented on the basis of product type, technology, end user, and geography.
By Product Type
- By Type
- Coagulation instrument
- Other instruments
- By Technology
- Reagents & Kits
By Test Type
- Prothrombin Test Time (PT)
- Activated Partial Thromboplastin Time (APTT)
- Fibrinogen Degradation Products (FDP)
- Activated Clotting Time, Platelet Aggregation Test
- D Dimer
- Independent Diagnostic
- North America
- Latin America
- Asia Pacific
- Middle East
To understand Research Methodology, please click https://www.coherentmarketinsights.com/ongoing-insight/hemostasis-diagnostics-market-434
Global Hemostasis Diagnostics Market: Regional Analysis
North America is expected to hold dominant position in the global hemostasis diagnostics market over the forecast period. This is attributed to factors such as increasing installation of hemostasis diagnostics instruments and significant incidence of hemophilia in the U.S. For instance, according to the Centers for Disease Control and Prevention, in 2015, 20,000 people in the U.S. suffered from hemophilia.
Increasing prevalence of hemophilia is expected to aid in growth of the market in Europe. For instance, according to The European National Registry of Congenital Coagulopathies, 2017, the number of people suffering from hemostasis increased from 7000 in 2000 to over 11,000 in 2015.
The markets in emerging regions such as Asia Pacific and Latin America are driven by increasing healthcare expenditure and disposable income of the populace.
Global Hemostasis Diagnostics Market: Competitive Landscape
Major players operating in the global hemostasis diagnostics market include, HORIBA, Ltd., Abbott Laboratories, Siemens AG, Bio-Rad Laboratories, Inc., Becton, Dickinson & Company, Grifols S.A, Alere, Inc., F. Hoffmann-La Roche AG, Beckman Coulter Inc. Sekisui, Helena Labor, Chrono-Log, and Axis-Shield.
Share your precise requirements @ https://www.coherentmarketinsights.com/insight/request-customization/434
Global Hemostasis Diagnostics Market: Key Developments
- In February 2019, Horiba Medical, launched their new parameter, Yumizen D-Dimer, for its Yumizen G Hemostasis range of instruments to diagnose deep vein thrombosis and pulmonary embolism.
- In 2017, Werfen and it’s subsidiary Instrumentation Laboratory Company acquired Accriva Diagnostics, to expand leadership in point of care testing.
- In 2016, Siemens Healthineers launched Sysmex CS-2500 a new mid-volume coagulation analyzer. Which enable labs to provide quality test results and achieve cost-effective method consolidation.
- In 2015, Roche AG launched the new lab-coagulation solution, the cobas t 411 analyzer is lab coagulation system suitable for low volume routine testing (up to 120 samples per day), with this launch Roche AG expanded their diagnostic portfolio.
- In 2014, Sysmex Corporation, launched LIASAUTO P-FDP hemostasis reagent for automated coagulation analyzers to determine the status of blood hyperfibrinolysis and hypercoagulable
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
- CDN Newswire